- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03488342
Rives Technique Versus Lichtenstein Repair for Primary Inguinal Hernia
March 28, 2018 updated by: José Jacob Motos Micó, Hospital Siberia-Serena
Randomized Clinical Trial of Rives Technique Versus Lichtenstein Repair for Primary Inguinal Hernia
Lichtenstein technique, inserting a mesh over the inguinal cord in the neurological plane, is considered the standard of inguinal hernia repair, but it has 4% recurrence and 12% chronic postoperative pain.
Rives technique inserts the mesh in the preperitoneal space behind the neurological plane and the muscular plane, thus better fulfilling the principle of hydrostatics.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
These techniques have not been compared randomly for assessment of chronic pain, postoperative complications and recurrences
Study Type
Interventional
Enrollment (Anticipated)
600
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Badajoz
-
Talarrubias, Badajoz, Spain, 06640
- Recruiting
- Hospital Siberia Serena
-
Contact:
- Enrique Javier Grau Talens, PhD
- Phone Number: +34616182400
- Email: ejgtalens@yahoo.es
-
Contact:
- José Jacob Motos Micó, MD
- Phone Number: +34633257986
- Email: jacob_motos@hotmail.com
-
Principal Investigator:
- Enrique Javier Grau Talens, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 93 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Men or women aged between 18 and 93 years (inclusive) at the time of the first screening visit.
They must provide signed written informed consent and agree to comply the study protocol
Exclusion Criteria:
Refusal to give informed consent. Refusal to participate giant inguinal hernias
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Rives technique
Rives technique for primary inguinal hernia
|
Repair for primary inguinal hernia
|
|
OTHER: Lichtenstein repair
Lichtenstein repair for primary inguinal hernia
|
Repair for primary inguinal hernia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate postoperative complications of pain
Time Frame: 7 days
|
The patients are clinically reviewed in the office within 7 days of discharge (pain is evaluated at rest and with movement (standing up, sitting down, and walking), using a VAS (visual analogue scale).
Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100.
A higher score indicates greater pain intensity.
Based on the distribution of pain VAS scores in post- surgical patients, the following cut points on the pain VAS have been recommended: no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm)
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate the chronic pain
Time Frame: 1 year
|
The patients are reviewed clinically by the service's surgeons again after a year.
If pain is found, this is evaluated as being with movement, spontaneous, episodic, or constant in nature, and measured with a VAS.
The patients are clinically reviewed in the office: pain is evaluated at rest and with movement (standing up, sitting down, and walking), using a VAS (visual analogue scale).
Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100.
A higher score indicates greater pain intensity.
Based on the distribution of pain VAS scores in post- surgical patients, the following cut points on the pain VAS have been recommended: no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm)
|
1 year
|
|
Evaluate the recurrences
Time Frame: 1 year
|
The patients are reviewed clinically by the service's surgeons again after a year.
The inguinal region is examined.
A mass, reducible or otherwise, is regarded as a recurrence.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2015
Primary Completion (ANTICIPATED)
November 1, 2018
Study Completion (ANTICIPATED)
November 1, 2018
Study Registration Dates
First Submitted
March 22, 2018
First Submitted That Met QC Criteria
March 28, 2018
First Posted (ACTUAL)
April 5, 2018
Study Record Updates
Last Update Posted (ACTUAL)
April 5, 2018
Last Update Submitted That Met QC Criteria
March 28, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSiberia-Serena
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Inguinal Hernia
-
Insightra Medical, Inc.Terminated
-
National University Hospital, SingaporeCompletedPrimary Unilateral Inguinal HerniaSingapore
-
Rambam Health Care CampusTerminatedOpen Surgery | Primary Inguinal Hernia | Unilateral HerniaIsrael
-
University Hospital, GhentCompletedPrimary Unilateral Inguinal HerniasBelgium
-
Pirogov Russian National Research Medical UniversityRecruitingPrimary Inguinal HerniaRussian Federation
-
Helsinki University Central HospitalMedtronic - MITGCompletedInguinal Hernia | Primary | UnilateralFinland
-
Children's Mercy Hospital Kansas CityCompletedInguinal Hernia | Inguinal Hernia, Indirect | Inguinal Hernia Unilateral | Inguinal Hernia BilateralUnited States
-
Hospital General Universitario ElcheCompletedInguinal Hernia | Inguinal Hernia Repair | Open Inguinal Hernia
-
San Bonifacio HospitalCompletedIndirect Inguinal Hernia | Direct Inguinal HerniaItaly
-
Sohag UniversityRecruiting
Clinical Trials on Repair for primary inguinal hernia
-
Assiut UniversityEnrolling by invitationInguinal Hernia | Inguinal Hernia RepairEgypt
-
Sohag UniversityRecruitingCongenital Inguinal HerniaEgypt
-
The Cleveland ClinicCompleted
-
Algemeen Ziekenhuis Maria MiddelaresCompletedInguinal HerniaBelgium
-
The Sydney Hernia Specialists ClinicUniversity of SydneyCompletedInguinal HerniaAustralia
-
Ann & Robert H Lurie Children's Hospital of ChicagoJohns Hopkins UniversityCompletedInguinal HerniaUnited States
-
General Hospital of LarissaUnknown
-
Akdeniz UniversityCompleted
-
Hospital Clinic of BarcelonaRecruiting